Bristol-Myers Squibb Company (BMY)
NYSE · Healthcare
Bristol-Myers Squibb Company Total Liabilities 2007–2025
Bristol-Myers Squibb Company annual total liabilities history from 2008 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Bristol-Myers Squibb Company total liabilities as of December 31, 2025: 71.53B, a 6.14% decrease year-over-year.
- Bristol-Myers Squibb Company total liabilities for 2025 were 71.53B, a 6.14% decrease from 2024.
- Bristol-Myers Squibb Company total liabilities for 2024 were 76.22B, a 16.05% increase from 2023.
- Bristol-Myers Squibb Company total liabilities for 2023 were 65.67B, a 0.04% decrease from 2022.
- Bristol-Myers Squibb Company total liabilities for 2022 were 65.70B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Bristol-Myers Squibb Company Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $71,533 |
| 2024 | $76,215 |
| 2023 | $65,674 |
| 2022 | $65,702 |
| 2021 | $73,308 |
| 2020 | $80,599 |
| 2019 | $78,246 |
| 2018 | $20,859 |
| 2017 | $21,704 |
| 2016 | $17,360 |
| 2015 | $17,324 |
| 2014 | $18,766 |
| 2013 | $23,356 |
| 2012 | $22,259 |
| 2011 | $17,103 |
Bristol-Myers Squibb Company Total Liabilities — FAQ
Bristol-Myers Squibb Company (BMY) total liabilities over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMY's total liabilities history?
The chart and table above show Bristol-Myers Squibb Company's total liabilities by year and by quarter, including the growth rate.